Experimental CAR T therapy targets tumor’s immune shield, not cancer cells directly
by The Mount Sinai Hospital edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Graphical abstract. Credit: Cancer Cell (2026). DOI: 10.1016/j.ccell.2025.12.021 Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it […]
Experimental CAR T therapy targets tumor’s immune shield, not cancer cells directly Read More »
